TruSpine Technologies Plc float on the Aquis Stock Exchange
TruSpine is a medical device company in the spinal device market. The Company is developing disruptive technologies for use in the spinal stabilisation market, commencing with the following three devices:
- Cervi-LOK – for the cervical and upper thoracic spine;
- Faci-LOK – for the lumbar and lower thoracic spine; and
- GRASP Laminoplasty – a treatment for decompression of the spinal cord.
These devices represent a potentially significant development in spinal fixation, by providing stabilisation while not altering the bony spinal anatomy of patients through the use of screws, staples or other devices which currently dominate the spinal market.
Admission to trading on the Aquis Stock Exchange
Admission to trading on the Aquis Stock Exchange Growth Market and commencement of dealings in the Ordinary Shares became effective on 20 August and the Share Capital on admission was 87,778,967 Ordinary Shares of 0.01 pence each.
The Perivan shareholder and investor communications team were delighted to work closely with the Cairn Financial Advisers LLP the Company’s Aquis Stock Exchange Corporate Adviser on the successful 79-page admission document.
Perivan specialise in the production and publication of financial documents relating to shareholder and investor communications for quoted companies, private companies and open and closed ended funds.